H Lundbeck A/S (HLUYY) 28.7300 $HLUYY 3 Reasons Why H.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
H Lundbeck A/S (HLUYY) 28.7300 $HLUYY

3 Reasons Why H. Lundbeck A/S (HLUYY) is a Great Momentum Stock
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 7:30AM CDT
H. Lundbeck A/S has a strong momentum score, a favorable Zacks Rank, and is seeing positive earnings estimate revisions as well

How H. Lundbeck A/S (HLUYY) Stock Stands Out in a Strong Industry
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 7:56AM CDT
H. Lundbeck A/S in the Large Cap Pharma space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective

European Stocks Drop More Than 1% on Weak Earnings
at The Street - Wed Aug 19, 6:29AM CDT
European stocks retreated on Wednesday, after weak earnings from mining giant Glencore, Danish brewer Carlsberg and others. The German parliament voted to approve the latest Greek bailout deal.

Is H. Lundbeck A/S (HLUYY) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 07, 7:36AM CDT
If you are looking for a decent pick in a strong industry, consider H. Lundbeck A/S

A New Beginning For Lundbeck, But Not A Clean Start
Stephen Simpson, CFA - at Seeking Alpha - Fri May 08, 8:12AM CDT


Phase 3 study shows efficacy of brexpiprazole in schizophrenia
Seeking Alpha - at Seeking Alpha - Fri Apr 17, 9:32AM CDT


Is Biogen A Buy? An Analysis Of Its Growth Drivers And Challenges
DoctoRx - at Seeking Alpha - Thu Apr 09, 12:28AM CDT

BIIB: 269.16 (-10.72), MDCO: 34.88 (+0.07), GILD: 100.65 (-0.16), MRK: 50.95 (-0.07), AZN: 32.23 (-0.16), LLY: 86.14 (+2.37), ABBV: 55.64 (-0.40), CELG: 117.38 (-0.59)

2015 could be the year of the blockbuster drug
Seeking Alpha - at Seeking Alpha - Mon Mar 23, 3:26PM CDT

VRTX: 110.00 (+0.97), PFE: 33.24 (+0.15), AMGN: 149.59 (-0.31), BMY: 61.44 (+0.93), GSK: 40.22 (+0.06), GILD: 100.65 (-0.16), MRK: 50.95 (-0.07), ABBV: 55.64 (-0.40), THRX: 8.64 (-0.11), SNY: 48.75 (+0.03), REGN: 503.92 (+12.71), NVS: 91.90 (-0.71)

Lundbeck Initiates Clinical Trial Evaluating Clobazam for Dravet Syndrome
Business Wire - Tue Mar 17, 9:00AM CDT
Lundbeck LLC today announced the initiation of the CLOVER I Study to investigate the use of clobazam for the treatment of children and adolescents with Dravet syndrome -- a rare and severe form of intractable epilepsy that begins in infancy.(1) Clobazam is already approved in the United States (U.S.) for seizures associated with another epilepsy syndrome.

Although Undervalued, Lundbeck Likely Stuck Until New Drugs Start Ramping
Stephen Simpson, CFA - at Seeking Alpha - Mon Feb 09, 11:00AM CST


XenoPort Prepping For Key Data In 2015
Stephen Simpson, CFA - at Seeking Alpha - Wed Jan 14, 4:59PM CST

BIIB: 269.16 (-10.72), FWP: 27.74 (+0.87), ALKS: 60.82 (+0.92), XNPT: 4.19 (+0.26)

Lundbeck Continues To Fight To Stand Out
Stephen Simpson, CFA - at Seeking Alpha - Thu Dec 18, 10:53AM CST

JNJ: 95.37 (+0.29)

New Study: Art Therapy May Build Self-Esteem in People Living with Epilepsy
Business Wire - Mon Dec 08, 10:00AM CST
--Studio E Artwork on Display Across the Country to Raise Epilepsy Awareness

Five-Year Data From SABRIL(R) (vigabatrin) Registry Presented at American Epilepsy Society Annual Meeting
Business Wire - Mon Dec 08, 10:00AM CST
A late-breaking poster presentation focused on five-year vision data from Lundbeck's SABRIL (vigabatrin) patient registry was presented at the annual meeting of the American Epilepsy Society (AES). The data set includes 6,823 patients enrolled from August 21, 2009 through August 26, 2014.(1) The U.S. Food and Drug Administration (FDA) requires a Risk Evaluation and Mitigation Strategy (REMS) due to the risk of SABRIL-induced permanent vision loss, including an ongoing patient registry.

Lundbeck Partners with the Hereditary Disease Foundation, Pledges Five Additional Years of Support for Build Hope for Huntington's Disease Campaign
Business Wire - Thu Nov 06, 8:00AM CST
Today, Lundbeck and the Hereditary Disease Foundation announced the launch of the fifth annual Build Hope for Huntington's Disease (HD) initiative. The online donation campaign helps support the Casa Hogar Corea de Huntington Amor y Fe (Huntington's Chorea Home of Love and Faith). This clinic provides care for the Venezuelan families who were essential in leading to groundbreaking discoveries in HD and other genetic diseases. To prompt a donation from Lundbeck, visit www.BuildHopeforHD.com or www.hdfoundation.org and click on the campaign icon. For every click before the end of the year, Lundbeck will donate $15 to the clinic, up to $25,000.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 96

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 80

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 103

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 59

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 59

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Fly Play hf. Amid Takeover Talks

Updated Category News Views 224

Understanding the Recent Developments at Fly Play hf. Fly Play hf. is currently navigating through a significant phase in its operational journey. Amid potential takeover discussions, stakeholders are keenly interested in how such a move could reshape the airline's direction. As the aviation industry continues to evolve, Fly Play's adaptability and innovative strategies...

Continue Reading
AvePoint Aims for Dual Listing at Singapore Exchange

Updated Category News Views 275

AvePoint's Ambitious Step Towards Dual Listing AvePoint (Nasdaq: AVPT), renowned as a leader in data security, governance, and resilience, is taking a significant step forward by submitting an application to list its shares on the Singapore Exchange Securities Trading Limited (SGX-ST). This application is set against the backdrop of its existing presence on the Nasdaq...

Continue Reading
Kris Kehl Joins Planet Home Lending to Enhance Services

Updated Category News Views 140

Kris Kehl Joins Planet Home Lending Team Planet Home Lending, a prominent national mortgage lender, is excited to announce the addition of Kris Kehl as a Senior Mortgage Loan Officer in California. With over 22 years of extensive experience in the mortgage industry, Kehl brings a relationship-first approach that prioritizes accessibility, clear communication, and...

Continue Reading
The S&P 500: Understanding Future Market Return Challenges

Updated Category News Views 647

Understanding Future Returns for the S&P 500 Recently, there’s been a surge of interest regarding predictions for future returns of the S&P 500. With insights from financial giants like J.P. Morgan and Goldman Sachs indicating a significantly lower return forecast for the coming decade, it’s essential to delve deeper into these evaluations. The consistent message has...

Continue Reading
Investors Can Seize Winds of Change with enCore Energy

Updated Category News Views 183

Understanding the Opportunity with enCore Energy Corp. Investors are currently presented with a significant opportunity to engage in the ongoing developments at enCore Energy Corp. (NASDAQ: EU). The global landscape is rapidly changing, especially in the energy sector, and enCore is no exception. A class action has been filed on behalf of shareholders who purchased...

Continue Reading